Year: 2025
Type: article
Abstract: Transcatheter aortic valve replacement (TAVR) has revolutionized the treatment landscape for severe symptomatic aortic stenosis among all surgical risk groups. Thus, following the expansion of TAVR use and constant improvements in TAVR platforms and implantation techniques, implementation has been extended to special population groups that were previously underrepresented in clinical trials. This review evaluates the role of TAVR in patients with unique clinical considerations, including those with active malignancies, psychiatric disorders, and advanced organ dysfunction. By examining current literature, we provide insights into the safety, efficacy, appropriateness, and specific challenges associated with TAVR in these patient groups.
DOI: 10.31083/rcm45993
Institution: University of Missouri–Kansas City
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,200
OpenAlex ID: W4417153274
